Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ubiquitin-like ligase-substrate adaptor activity	PRAMEF9 PRAMEF15 PRAMEF4 FBXO38 PRAMEF27 PRAMEF11	5.28e-05	82	161	6	GO:1990756
GeneOntologyMolecularFunction	enzyme-substrate adaptor activity	PRAMEF9 PRAMEF15 PRAMEF4 FBXO38 PRAMEF27 PRAMEF11	1.20e-04	95	161	6	GO:0140767
GeneOntologyBiologicalProcess	positive regulation of chromosome condensation	NCAPH2 NCAPG2 NCAPD2	2.40e-05	8	158	3	GO:1905821
GeneOntologyBiologicalProcess	female gamete generation	PRAMEF15 YTHDC2 NCAPH2 PRAMEF4 TTK ASPM HFM1 NOS3 PRAMEF11	5.72e-05	223	158	9	GO:0007292
GeneOntologyBiologicalProcess	establishment of vesicle localization	GBF1 CLASP1 MYO5B FAM91A1 CLASP2 AP1G1 WDR11 CADPS2 KIF1C	5.92e-05	224	158	9	GO:0051650
GeneOntologyBiologicalProcess	positive regulation of chromosome segregation	NCAPH2 NCAPG2 MAD2L1BP NCAPD2	6.78e-05	29	158	4	GO:0051984
GeneOntologyBiologicalProcess	regulation of wound healing, spreading of epidermal cells	CLASP1 CLASP2 MTOR	6.96e-05	11	158	3	GO:1903689
GeneOntologyBiologicalProcess	meiotic cell cycle	YTHDC2 CLASP2 NCAPH2 TEX11 TTK FANCD2 NCAPD2 ASPM CCNA1 HFM1 CDC25A	8.38e-05	350	158	11	GO:0051321
GeneOntologyBiologicalProcess	positive regulation of chromosome separation	NCAPH2 NCAPG2 MAD2L1BP NCAPD2	8.88e-05	31	158	4	GO:1905820
GeneOntologyBiologicalProcess	basement membrane assembly	CLASP1 CLASP2 PXDN	9.22e-05	12	158	3	GO:0070831
GeneOntologyBiologicalProcess	nuclear chromosome segregation	CLASP1 CLASP2 NCAPH2 TEX11 TTK NCAPG2 MAD2L1BP FANCD2 NCAPD2 ASPM DYNC1H1	9.75e-05	356	158	11	GO:0098813
GeneOntologyBiologicalProcess	focal adhesion assembly	STON1 CLASP1 WHAMM CLASP2 TLN1 KDR	1.02e-04	97	158	6	GO:0048041
GeneOntologyBiologicalProcess	vesicle localization	GBF1 CLASP1 MYO5B FAM91A1 CLASP2 AP1G1 WDR11 CADPS2 KIF1C	1.25e-04	247	158	9	GO:0051648
GeneOntologyBiologicalProcess	regulation of chromosome condensation	NCAPH2 NCAPG2 NCAPD2	1.51e-04	14	158	3	GO:0060623
GeneOntologyBiologicalProcess	sexual reproduction	ADAD1 DNHD1 PRAMEF15 YTHDC2 CLASP2 NCAPH2 PRAMEF4 TEX11 PKDREJ TTK FANCD2 USP26 CCNYL1 MTOR MROH2B NCAPD2 ASPM CCNA1 HFM1 CDC25A SPOCD1 NOS3 PRAMEF11	1.68e-04	1312	158	23	GO:0019953
GeneOntologyBiologicalProcess	cell-substrate junction assembly	STON1 CLASP1 WHAMM CLASP2 TLN1 KDR	1.85e-04	108	158	6	GO:0007044
GeneOntologyBiologicalProcess	embryonic body morphogenesis	CLASP1 CLASP2 IFT122	1.88e-04	15	158	3	GO:0010172
GeneOntologyBiologicalProcess	gamete generation	ADAD1 DNHD1 PRAMEF15 YTHDC2 NCAPH2 PRAMEF4 TEX11 TTK FANCD2 USP26 CCNYL1 MTOR MROH2B ASPM CCNA1 HFM1 SPOCD1 NOS3 PRAMEF11	1.91e-04	982	158	19	GO:0007276
GeneOntologyBiologicalProcess	vesicle targeting	GBF1 CLASP1 FAM91A1 CLASP2 WDR11	2.14e-04	71	158	5	GO:0006903
GeneOntologyBiologicalProcess	meiotic cell cycle process	NCAPH2 TEX11 TTK FANCD2 NCAPD2 ASPM CCNA1 HFM1 CDC25A	2.30e-04	268	158	9	GO:1903046
GeneOntologyBiologicalProcess	cell cycle process	ATR RASA1 CLASP1 STXBP4 YTHDC2 CLASP2 NCAPH2 TEX11 TTK NCAPG2 MAD2L1BP FANCD2 USP26 JTB NCAPD2 ASPM CCNA1 HFM1 TIMELESS SLFN11 CDC25A DSCC1 DYNC1H1 RAD9A	2.58e-04	1441	158	24	GO:0022402
GeneOntologyBiologicalProcess	cell-substrate junction organization	STON1 CLASP1 WHAMM CLASP2 TLN1 KDR	2.60e-04	115	158	6	GO:0150115
GeneOntologyBiologicalProcess	mitotic cell cycle	GBF1 ATR RASA1 CLASP1 YTHDC2 CLASP2 NCAPH2 TTK NCAPG2 MAD2L1BP FANCD2 USP26 JTB NCAPD2 CCNA1 SLFN11 CDC25A DYNC1H1 RAD9A	2.86e-04	1014	158	19	GO:0000278
GeneOntologyBiologicalProcess	mitotic cell cycle process	ATR RASA1 CLASP1 CLASP2 NCAPH2 TTK NCAPG2 MAD2L1BP FANCD2 USP26 JTB NCAPD2 CCNA1 SLFN11 CDC25A DYNC1H1 RAD9A	3.05e-04	854	158	17	GO:1903047
GeneOntologyBiologicalProcess	positive regulation of cholangiocyte proliferation	MTOR CDC25A	3.46e-04	4	158	2	GO:1904056
GeneOntologyBiologicalProcess	replication fork arrest	TIMELESS SLFN11	3.46e-04	4	158	2	GO:0043111
GeneOntologyBiologicalProcess	regulation of chromosome separation	NCAPH2 TTK NCAPG2 MAD2L1BP NCAPD2	3.53e-04	79	158	5	GO:1905818
GeneOntologyBiologicalProcess	epiboly involved in wound healing	CLASP1 CLASP2 ARHGAP35 MTOR	4.21e-04	46	158	4	GO:0090505
GeneOntologyBiologicalProcess	wound healing, spreading of cells	CLASP1 CLASP2 ARHGAP35 MTOR	4.21e-04	46	158	4	GO:0044319
GeneOntologyCellularComponent	condensin complex	NCAPH2 NCAPG2 NCAPD2	2.49e-05	8	162	3	GO:0000796
GeneOntologyCellularComponent	Cul2-RING ubiquitin ligase complex	PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	3.10e-05	47	162	5	GO:0031462
GeneOntologyCellularComponent	caspase complex	CAPNS1 CAPNS2 CASP9	5.27e-05	10	162	3	GO:0008303
GeneOntologyCellularComponent	calpain complex	CAPNS1 CAPNS2	3.54e-04	4	162	2	GO:0110158
GeneOntologyCellularComponent	cortical microtubule cytoskeleton	CLASP1 CLASP2	5.88e-04	5	162	2	GO:0030981
GeneOntologyCellularComponent	condensed chromosome	CLASP1 CLASP2 NCAPH2 TEX11 TTK NCAPG2 FANCD2 NCAPD2 RAD9A	6.72e-04	307	162	9	GO:0000793
GeneOntologyCellularComponent	condensed nuclear chromosome	NCAPH2 TEX11 NCAPG2 NCAPD2 RAD9A	7.14e-04	91	162	5	GO:0000794
MousePheno	increased circulating LDL cholesterol level	CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A3 MTOR NOS3	5.97e-08	80	132	9	MP:0000182
MousePheno	abnormal circulating LDL cholesterol level	CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A3 MTOR NOS3	2.38e-05	163	132	9	MP:0000181
MousePheno	abnormal circulating non-HDL cholesterol level	CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A3 MTOR NOS3	5.20e-05	180	132	9	MP:0020151
Domain	INT_SG_DDX_CT_C	CT45A1 CT45A10 CT45A7 CT45A9 CT45A3	2.16e-09	8	157	5	PF15300
Domain	INT_SG_DDX_CT_C	CT45A1 CT45A10 CT45A7 CT45A9 CT45A3	2.16e-09	8	157	5	IPR029307
Domain	ARM-type_fold	GBF1 ATR CLASP1 DOCK11 ARFGEF1 NBEA CLASP2 NCAPG2 PPP4R3B AP1G1 MTOR MROH2B NCAPD2 ASPM PPP6R2	1.82e-07	339	157	15	IPR016024
Domain	ARM-like	ATR CLASP1 ARFGEF1 NBEA CLASP2 NCAPG2 PPP4R3B AP1G1 MTOR MROH2B NCAPD2 ASPM PPP6R2	4.81e-07	270	157	13	IPR011989
Domain	RmlC_Cupin	CT45A1 CT45A2 GGCX CT45A3	8.08e-06	16	157	4	IPR011051
Domain	HEAT	ATR CLASP1 CLASP2 NCAPG2 MTOR NCAPD2	9.05e-06	58	157	6	IPR000357
Domain	PRAME_family	PRAMEF25 PRAMEF15 PRAMEF4 PRAMEF27	1.69e-05	19	157	4	IPR026271
Domain	-	ATR CLASP1 ARFGEF1 CLASP2 NCAPG2 AP1G1 MTOR MROH2B NCAPD2 ASPM	1.88e-05	222	157	10	1.25.10.10
Domain	HEAT_REPEAT	ATR CLASP1 CLASP2 NCAPG2 MTOR MROH2B	2.70e-05	70	157	6	PS50077
Domain	HEAT	ATR CLASP1 CLASP2 NCAPG2 NCAPD2	5.04e-05	48	157	5	PF02985
Domain	SIM_C	SIM1 SIM2	7.02e-05	2	157	2	IPR010578
Domain	SIM_C	SIM1 SIM2	7.02e-05	2	157	2	PF06621
Domain	SIM_C	SIM1 SIM2	7.02e-05	2	157	2	PS51302
Domain	EF-hand_8	EFCAB6 CAPNS1 CAPNS2 RYR2	1.83e-04	34	157	4	PF13833
Domain	Dynein_HC_stalk	DNHD1 DNAH6 DYNC1H1	1.98e-04	14	157	3	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DNAH6 DYNC1H1	1.98e-04	14	157	3	IPR013602
Domain	DHC_N2	DNHD1 DNAH6 DYNC1H1	1.98e-04	14	157	3	PF08393
Domain	MT	DNHD1 DNAH6 DYNC1H1	1.98e-04	14	157	3	PF12777
Domain	von_Ebner_gland	OBP2B OBP2A	2.09e-04	3	157	2	IPR002450
Domain	DHC_fam	DNHD1 DNAH6 DYNC1H1	2.46e-04	15	157	3	IPR026983
Domain	Dynein_heavy	DNHD1 DNAH6 DYNC1H1	2.46e-04	15	157	3	PF03028
Domain	Dynein_heavy_dom	DNHD1 DNAH6 DYNC1H1	2.46e-04	15	157	3	IPR004273
Domain	PH_dom-like	RASA1 DOCK11 NBEA DGKH JAK1 PPP4R3B PLEKHG1 IPCEF1 TLN1 OSBPL5 FRMPD3 CADPS2	2.63e-04	426	157	12	IPR011993
Domain	CLASP_N	CLASP1 CLASP2	4.17e-04	4	157	2	PF12348
Domain	CLASP_N_dom	CLASP1 CLASP2	4.17e-04	4	157	2	IPR024395
Domain	Sec7_N	GBF1 ARFGEF1	4.17e-04	4	157	2	IPR032691
Domain	Sec7_N	GBF1 ARFGEF1	4.17e-04	4	157	2	PF12783
Domain	FATC	ATR MTOR	6.91e-04	5	157	2	PF02260
Domain	RIH_assoc-dom	RYR2 ITPR3	1.03e-03	6	157	2	IPR013662
Domain	Ins145_P3_rec	RYR2 ITPR3	1.03e-03	6	157	2	PF08709
Domain	RIH_assoc	RYR2 ITPR3	1.03e-03	6	157	2	PF08454
Domain	RIH_dom	RYR2 ITPR3	1.03e-03	6	157	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 ITPR3	1.03e-03	6	157	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 ITPR3	1.03e-03	6	157	2	IPR015925
Domain	FAT	ATR MTOR	1.03e-03	6	157	2	PS51189
Domain	FATC	ATR MTOR	1.03e-03	6	157	2	PS51190
Domain	-	RYR2 ITPR3	1.03e-03	6	157	2	1.25.10.30
Domain	FAT	ATR MTOR	1.03e-03	6	157	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR MTOR	1.03e-03	6	157	2	IPR003151
Domain	FATC_dom	ATR MTOR	1.03e-03	6	157	2	IPR003152
Domain	RYDR_ITPR	RYR2 ITPR3	1.03e-03	6	157	2	PF01365
Domain	PIK_FAT	ATR MTOR	1.03e-03	6	157	2	IPR014009
Domain	FATC	ATR MTOR	1.03e-03	6	157	2	SM01343
Domain	TFS2M	TCEA2 SPOCD1	1.43e-03	7	157	2	SM00510
Domain	TFIIS_M	TCEA2 SPOCD1	1.43e-03	7	157	2	PF07500
Domain	TFIIS_cen_dom	TCEA2 SPOCD1	1.90e-03	8	157	2	IPR003618
Domain	-	TCEA2 SPOCD1	1.90e-03	8	157	2	1.10.472.30
Domain	TFIIS_CENTRAL	TCEA2 SPOCD1	1.90e-03	8	157	2	PS51321
Domain	P-loop_NTPase	DNHD1 MYO5B PEX6 YTHDC2 ARHGAP35 ABCG1 ASPM SHPRH ABCD4 RASEF HFM1 SLFN11 CHST7 DNAH6 DYNC1H1 KIF1C	2.12e-03	848	157	16	IPR027417
Domain	Ion_trans_dom	CACNA1S RYR2 ITPR3 KCNG1 KCNQ2	2.77e-03	114	157	5	IPR005821
Domain	Ion_trans	CACNA1S RYR2 ITPR3 KCNG1 KCNQ2	2.77e-03	114	157	5	PF00520
Domain	EF-hand-dom_pair	CACNA1S EFCAB6 STXBP4 CAPNS1 CAPNS2 RYR2 EFHD1 RASEF	3.00e-03	287	157	8	IPR011992
Domain	MIR	RYR2 ITPR3	3.02e-03	10	157	2	PF02815
Domain	MIR_motif	RYR2 ITPR3	3.02e-03	10	157	2	IPR016093
Domain	MIR	RYR2 ITPR3	3.02e-03	10	157	2	PS50919
Domain	MIR	RYR2 ITPR3	3.02e-03	10	157	2	SM00472
Domain	PH	RASA1 DOCK11 DGKH PLEKHG1 IPCEF1 OSBPL5 CADPS2	3.28e-03	229	157	7	PF00169
Domain	TPR-like_helical_dom	ATR TEX11 TTK MTOR COPS4 IFT122 TANC1	3.61e-03	233	157	7	IPR011990
Domain	-	RASA1 DOCK11 DGKH PPP4R3B PLEKHG1 IPCEF1 TLN1 OSBPL5 CADPS2	5.90e-03	391	157	9	2.30.29.30
Domain	Dynein_heavy_chain_D4_dom	DNAH6 DYNC1H1	5.98e-03	14	157	2	IPR024317
Domain	ATPase_dyneun-rel_AAA	DNAH6 DYNC1H1	5.98e-03	14	157	2	IPR011704
Domain	AAA_8	DNAH6 DYNC1H1	5.98e-03	14	157	2	PF12780
Domain	AAA_5	DNAH6 DYNC1H1	5.98e-03	14	157	2	PF07728
Domain	-	EFCAB6 STXBP4 CAPNS1 CAPNS2 RYR2 EFHD1 RASEF	6.64e-03	261	157	7	1.10.238.10
Domain	Clathrin/coatomer_adapt-like_N	AP1G1 NCAPD2	6.86e-03	15	157	2	IPR002553
Domain	PI3/4_kinase_CS	ATR MTOR	6.86e-03	15	157	2	IPR018936
Domain	Adaptin_N	AP1G1 NCAPD2	6.86e-03	15	157	2	PF01602
Domain	-	GBF1 ARFGEF1	6.86e-03	15	157	2	1.10.1000.11
Domain	Sec7	GBF1 ARFGEF1	6.86e-03	15	157	2	PF01369
Domain	Sec7_alpha_orthog	GBF1 ARFGEF1	6.86e-03	15	157	2	IPR023394
Domain	AAA	PEX6 ABCG1 ABCD4 DNAH6 DYNC1H1	7.43e-03	144	157	5	SM00382
Domain	AAA+_ATPase	PEX6 ABCG1 ABCD4 DNAH6 DYNC1H1	7.43e-03	144	157	5	IPR003593
Domain	CARD	CASP9 CARD6	7.80e-03	16	157	2	SM00114
Domain	-	ATR MTOR	7.80e-03	16	157	2	1.10.1070.11
Domain	SEC7	GBF1 ARFGEF1	7.80e-03	16	157	2	PS50190
Domain	PI3Kc	ATR MTOR	7.80e-03	16	157	2	SM00146
Domain	Sec7	GBF1 ARFGEF1	7.80e-03	16	157	2	SM00222
Domain	Sec7_dom	GBF1 ARFGEF1	7.80e-03	16	157	2	IPR000904
Domain	FERM_central	JAK1 TLN1 FRMPD3	8.09e-03	49	157	3	IPR019748
Domain	FERM_domain	JAK1 TLN1 FRMPD3	8.09e-03	49	157	3	IPR000299
Domain	-	ATR TEX11 TTK MTOR IFT122 TANC1	8.17e-03	207	157	6	1.25.40.10
Pathway	PID_ATR_PATHWAY	ATR FANCD2 TIMELESS CDC25A RAD9A	1.88e-05	39	120	5	M46
Pubmed	Identification of cancer/testis-antigen genes by massively parallel signature sequencing.	CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5	4.77e-18	15	165	9	15905330
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	MYCBP2 CAPNS1 ELP1 FAM91A1 NCAPH2 TTK ARAF GGCX FANCD2 PPP4R3B VPS13D WDR11 MTOR NCAPD2 ECEL1 USP54 UBE3C	5.54e-09	606	165	17	36538041
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	CT45A6 CT45A1 PRMT8 GBF1 CT45A10 STXBP4 PRAMEF15 CT45A2 ELP1 NCAPH2 PRAMEF4 MYSM1 CT45A7 CT45A9 PLEKHG1 CT45A3 MTOR ASPM TIMELESS DSCC1 MGAT4C PRAMEF11	1.17e-07	1242	165	22	30973865
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SLC4A7 GBF1 CLASP1 RTCB MYCBP2 DOCK11 STXBP4 CLASP2 PAK6 TTK DENND2B ARAF PLEKHG1 VPS13D MTOR TANC1 USP54 KIF1C	1.67e-07	861	165	18	36931259
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	GBF1 MYCBP2 PEX6 CLASP2 ARHGAP35 ITPR3 PLEKHG1 KCNG1 MTOR SGSM2 TLN1 NCAPD2 OSBPL5 LRP4 KCNQ2 LRRC14 TANC1 UBE3C DYNC1H1 RAD9A	3.29e-07	1105	165	20	35748872
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PDPR MYO5B MYCBP2 STXBP4 ELP1 FAM91A1 NBEA CLASP2 RB1CC1 ITPR3 FANCD2 PPP4R3B FBXO38 WDR11 TANC1 SLFN11 CDC25A PPP6R2 FTSJ3	6.56e-07	1049	165	19	27880917
Pubmed	The WDR11 complex facilitates the tethering of AP-1-derived vesicles.	FAM91A1 AP1G1 WDR11	1.04e-06	5	165	3	29426865
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	RAG1 CYP2C18 ATR CASP9 PAK6 RB1CC1 MTOR KDR CDC25A NOS3 CX3CR1	1.04e-06	351	165	11	20453000
Pubmed	Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	2.23e-06	20	165	4	26694250
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ATR PEX6 ELP1 FAM91A1 YTHDC2 NCAPG2 ARAF AP1G1 WDR11 CARD6 TIMELESS IFT122 TANC1 PPP6R2	2.99e-06	650	165	14	38777146
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	GBF1 PDPR ATR CLASP1 RTCB ARFGEF1 PEX6 CLASP2 NCAPH2 ACAD10 RB1CC1 NCAPG2 S1PR3 FANCD2 JAK1 COPS4 TIMELESS UBE3C	3.29e-06	1061	165	18	33845483
Pubmed	Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	3.34e-06	22	165	4	31729367
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	STXBP4 CASP9 FAM91A1 TTK ARAF PLEKHG1 WDR11 TLN1 RASEF TANC1 USP54 UBE3C PPP6R2 DYNC1H1 KIF1C FTSJ3	3.40e-06	853	165	16	28718761
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ZNF211 CLASP1 DOCK11 CASP9 YTHDC2 NBEA CLASP2 ARAF VPS13D NCAPD2 SHPRH COPS4	4.98e-06	497	165	12	36774506
Pubmed	MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	5.72e-06	25	165	4	37451217
Pubmed	Overlapping and non-overlapping functions of condensins I and II in neural stem cell divisions.	NCAPH2 NCAPG2 NCAPD2	5.77e-06	8	165	3	25474630
Pubmed	Differential contributions of condensin I and condensin II to mitotic chromosome architecture in vertebrate cells.	NCAPH2 NCAPG2 NCAPD2	5.77e-06	8	165	3	14532007
Pubmed	Reconstitution and subunit geometry of human condensin complexes.	NCAPH2 NCAPG2 NCAPD2	5.77e-06	8	165	3	17268547
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	HSCB SLC4A7 PDPR MYCBP2 USE1 STXBP4 ELP1 CLASP2 RB1CC1 TTK NCAPG2 ITPR3 PLEKHG1 WDR11 TLN1 ASPM COPS4 IFT122 TANC1 PPP6R2 FTSJ3	8.28e-06	1487	165	21	33957083
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	MYCBP2 ELP1 NCAPH2 ARAF JAK1 SHPRH UBE3C PPP6R2	8.45e-06	212	165	8	33853758
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	9.15e-06	28	165	4	25089626
Pubmed	An abundance of X-linked genes expressed in spermatogonia.	PRAMEF15 PRAMEF4 TEX11 USP26 PRAMEF11	9.21e-06	59	165	5	11279525
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	GBF1 FAM91A1 YTHDC2 ARHGAP35 TTK WDR11 TLN1 TANC1	9.68e-06	216	165	8	31519766
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	GBF1 CLASP1 DOCK11 STXBP4 ELP1 CLASP2 ARAF PLEKHG1 USP54 PPP6R2 KIF1C	1.02e-05	446	165	11	24255178
Pubmed	Condensins I and II are essential for construction of bivalent chromosomes in mouse oocytes.	NCAPH2 NCAPG2 NCAPD2	1.23e-05	10	165	3	21795393
Pubmed	Homeostatic Control of Innate Lung Inflammation by Vici Syndrome Gene Epg5 and Additional Autophagy Genes Promotes Influenza Pathogenesis.	RAG1 RB1CC1 EPG5	1.23e-05	10	165	3	26764600
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	MYO5B MYCBP2 STXBP4 USP25 UQCC2 YTHDC2 MAD2L1BP GGCX FANCD2 WDR11 MTOR USP54 UBE3C FTSJ3	1.60e-05	754	165	14	33060197
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	SLC4A7 GBF1 USE1 FAM91A1 YTHDC2 TTK GGCX ITPR3 VPS13D WDR11 TLN1 TANC1	1.88e-05	568	165	12	37774976
Pubmed	Mammalian CLASP1 and CLASP2 cooperate to ensure mitotic fidelity by regulating spindle and kinetochore function.	CLASP1 CLASP2	2.24e-05	2	165	2	16914514
Pubmed	Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population.	EGLN1 CX3CR1	2.24e-05	2	165	2	24220244
Pubmed	Formyl Peptide Receptor 1 Modulates Endothelial Cell Functions by NADPH Oxidase-Dependent VEGFR2 Transactivation.	ATR KDR	2.24e-05	2	165	2	29743977
Pubmed	Hijacking components of the cellular secretory pathway for replication of poliovirus RNA.	GBF1 ARFGEF1	2.24e-05	2	165	2	17079330
Pubmed	Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe.	ATR TIMELESS	2.24e-05	2	165	2	37144518
Pubmed	Wide long lasting perinuclear Ca2+ release events generated by an interaction between ryanodine and IP3 receptors in canine Purkinje cells.	RYR2 ITPR3	2.24e-05	2	165	2	18586264
Pubmed	A critical role for ABCG1 in macrophage inflammation and lung homeostasis.	ABCG1 CX3CR1	2.24e-05	2	165	2	18322240
Pubmed	A Genome-wide CRISPR Screen Identifies CDC25A as a Determinant of Sensitivity to ATR Inhibitors.	ATR CDC25A	2.24e-05	2	165	2	27067599
Pubmed	High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation.	S1PR3 KDR	2.24e-05	2	165	2	29450744
Pubmed	Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics.	CLASP1 CLASP2	2.24e-05	2	165	2	12837247
Pubmed	Evidence of an odorant-binding protein in the human olfactory mucus: location, structural characterization, and odorant-binding properties.	OBP2B OBP2A	2.24e-05	2	165	2	12044155
Pubmed	Regulatory mechanisms and pathophysiological significance of IP3 receptors and ryanodine receptors in drug dependence.	RYR2 ITPR3	2.24e-05	2	165	2	24285081
Pubmed	A novel nuclear localization signal in the human single-minded proteins SIM1 and SIM2.	SIM1 SIM2	2.24e-05	2	165	2	14697214
Pubmed	Endothelial nitric oxide synthase gene expression during murine embryogenesis: commencement of expression in the embryo occurs with the establishment of a unidirectional circulatory system.	KDR NOS3	2.24e-05	2	165	2	18556578
Pubmed	Critical role of vascular peroxidase 1 in regulating endothelial nitric oxide synthase.	PXDN NOS3	2.24e-05	2	165	2	28264790
Pubmed	Oxysterol-binding protein-related protein 5 (ORP5) promotes cell proliferation by activation of mTORC1 signaling.	MTOR OSBPL5	2.24e-05	2	165	2	29358326
Pubmed	Murine Beta-Amyloid (1-42) Oligomers Disrupt Endothelial Barrier Integrity and VEGFR Signaling via Activating Astrocytes to Release Deleterious Soluble Factors.	KDR NOS3	2.24e-05	2	165	2	35163801
Pubmed	Mammalian CLASPs are required for mitotic spindle organization and kinetochore alignment.	CLASP1 CLASP2	2.24e-05	2	165	2	16866869
Pubmed	Golgi-derived CLASP-dependent microtubules control Golgi organization and polarized trafficking in motile cells.	CLASP1 CLASP2	2.24e-05	2	165	2	19701196
Pubmed	Cloning of two human homologs of the Drosophila single-minded gene SIM1 on chromosome 6q and SIM2 on 21q within the Down syndrome chromosomal region.	SIM1 SIM2	2.24e-05	2	165	2	9199934
Pubmed	Single-minded--two genes, three chromosomes.	SIM1 SIM2	2.24e-05	2	165	2	9199929
Pubmed	Overexpression of mSim2 gene in the zona limitans of the diencephalon of segmental trisomy 16 Ts1Cje fetuses, a mouse model for trisomy 21: a novel whole-mount based RNA hybridization study.	SIM1 SIM2	2.24e-05	2	165	2	10837894
Pubmed	Selective stimulation of VEGFR2 accelerates progressive renal disease.	KDR NOS3	2.24e-05	2	165	2	21640973
Pubmed	A novel human odorant-binding protein gene family resulting from genomic duplicons at 9q34: differential expression in the oral and genital spheres.	OBP2B OBP2A	2.24e-05	2	165	2	10607840
Pubmed	Paternal USP26 mutations raise Klinefelter syndrome risk in the offspring of mice and humans.	TEX11 USP26	2.24e-05	2	165	2	33978233
Pubmed	Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells.	RAG1 CX3CR1	2.24e-05	2	165	2	20432234
Pubmed	CD4+ T-Cell Responses Mediate Progressive Neurodegeneration in Experimental Ischemic Retinopathy.	RAG1 CX3CR1	2.24e-05	2	165	2	32389572
Pubmed	Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation.	RASA1 ARHGAP35	2.24e-05	2	165	2	9034330
Pubmed	Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis.	NOS3 CX3CR1	2.24e-05	2	165	2	16026776
Pubmed	TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt-mTOR pathway.	TTK MTOR	2.24e-05	2	165	2	32530571
Pubmed	ATR couples FANCD2 monoubiquitination to the DNA-damage response.	ATR FANCD2	2.24e-05	2	165	2	15314022
Pubmed	Mast, a conserved microtubule-associated protein required for bipolar mitotic spindle organization.	CLASP1 CLASP2	2.24e-05	2	165	2	10899121
Pubmed	Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.	RAG1 S1PR3	2.24e-05	2	165	2	26286732
Pubmed	Capns1, a new binding partner of RasGAP-SH3 domain in K-Ras(V12) oncogenic cells: modulation of cell survival and migration.	RASA1 CAPNS1	2.24e-05	2	165	2	18761085
Pubmed	p120RasGAP is a mediator of rho pathway activation and tumorigenicity in the DLD1 colorectal cancer cell line.	RASA1 ARHGAP35	2.24e-05	2	165	2	24465899
Pubmed	A role for cyclin A1 in the activation of MPF and G2-M transition during meiosis of male germ cells in mice.	CCNA1 CDC25A	2.24e-05	2	165	2	10926775
Pubmed	Fanconi anemia and mTOR pathways functionally interact during stalled replication fork recovery.	FANCD2 MTOR	2.24e-05	2	165	2	33423298
Pubmed	Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	2.28e-05	35	165	4	19389355
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	GBF1 ATR ARFGEF1 NCAPH2 NCAPG2 AP1G1 MTOR	2.87e-05	183	165	7	23956138
Pubmed	Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest.	IFNA2 IFNA6 CDC25A	3.67e-05	14	165	3	8668211
Pubmed	Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation.	NCAPH2 NCAPG2 NCAPD2	3.67e-05	14	165	3	26166704
Pubmed	Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.	ATR DOCK11 STXBP4 CAPNS1 NARS1 ELP1 FAM91A1 UQCC2 MAD2L1BP FANCD2 WDR11 COPS4 CCNA1 CDC25A FTSJ3	4.06e-05	931	165	15	27432908
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYCBP2 USP25 NARS1 WHAMM NBEA NCAPH2 SIM2 JAK1 PPP4R3B RPRD1A SGSM2 COPS4 LRP4 KCNQ2 IFT122 USP54 CADPS2 DYNC1H1	4.25e-05	1285	165	18	35914814
Pubmed	HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes.	ATR TEX11 USP26	4.58e-05	15	165	3	22530760
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	OBP2A USE1 ARFGEF1 ELP1 NCAPG2 ITPR3 FANCD2 PXDN RPRD1A AP1G1 MTOR TLN1 NCAPD2 TIMELESS DYNC1H1	4.64e-05	942	165	15	31073040
Pubmed	Laminar organization of the early developing anterior hypothalamus.	SIM1 SIM2 ALCAM	5.61e-05	16	165	3	16860307
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	GBF1 CLASP1 MYCBP2 YTHDC2 CLASP2 TEX11 GGCX CADPS2 DNAH6	6.13e-05	361	165	9	26167880
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	CACNA1S GBF1 RTCB CAPNS1 USP25 NARS1 ELP1 FANCD2 PPP4R3B RPRD1A AP1G1 MTOR TLN1 NCAPD2 COPS4 TIMELESS UBE3C TALDO1 DYNC1H1	6.59e-05	1455	165	19	22863883
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	STON1 CLASP1 YTHDC2 CLASP2 ARHGAP35 VPS13D TANC1	6.67e-05	209	165	7	36779422
Pubmed	HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.	S1PR3 NOS3	6.69e-05	3	165	2	14966566
Pubmed	Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells.	KDR NOS3	6.69e-05	3	165	2	21658307
Pubmed	Correlation between BTG3, CASP9 and LRP4 single-nucleotide polymorphisms and susceptibility to papillary thyroid carcinoma.	CASP9 LRP4	6.69e-05	3	165	2	35362324
Pubmed	Possible pheromone-carrier function of two lipocalin proteins in the vomeronasal organ.	OBP2B OBP2A	6.69e-05	3	165	2	7813422
Pubmed	PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI-Resistant Metastatic Clear Cell Renal Cell Carcinoma.	MTOR KDR	6.69e-05	3	165	2	35240013
Pubmed	CLASP2 Links Reelin to the Cytoskeleton during Neocortical Development.	CLASP1 CLASP2	6.69e-05	3	165	2	28285824
Pubmed	Unique role for dentate gyrus microglia in neuroblast survival and in VEGF-induced activation.	KDR CX3CR1	6.69e-05	3	165	2	30453385
Pubmed	Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes.	RYR2 NOS3	6.69e-05	3	165	2	18077344
Pubmed	Physical mapping of the holoprosencephaly critical region in 21q22.3, exclusion of SIM2 as a candidate gene for holoprosencephaly, and mapping of SIM2 to a region of chromosome 21 important for Down syndrome.	SIM1 SIM2	6.69e-05	3	165	2	7485157
Pubmed	cDNA cloning of a murine homologue of Drosophila single-minded, its mRNA expression in mouse development, and chromosome localization.	SIM1 SIM2	6.69e-05	3	165	2	8561800
Pubmed	Adipose-derived lipocalin 14 alleviates hyperglycaemia by suppressing both adipocyte glycerol efflux and hepatic gluconeogenesis in mice.	OBP2B OBP2A	6.69e-05	3	165	2	26592241
Pubmed	TIMELESS regulates sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancer.	ACER2 TIMELESS	6.69e-05	3	165	2	33093451
Pubmed	The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia.	EGLN1 MTOR	6.69e-05	3	165	2	28199842
Pubmed	Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts.	MTOR KDR	6.69e-05	3	165	2	24952635
Pubmed	Glomerular endothelial PI3 kinase-α couples to VEGFR2, but is not required for eNOS activation.	KDR NOS3	6.69e-05	3	165	2	21937609
Pubmed	The Sec7 guanine nucleotide exchange factor GBF1 regulates membrane recruitment of BIG1 and BIG2 guanine nucleotide exchange factors to the trans-Golgi network (TGN).	GBF1 ARFGEF1	6.69e-05	3	165	2	23386609
Pubmed	Novel regulation of checkpoint kinase 1: Is checkpoint kinase 1 a good candidate for anti-cancer therapy?	ATR CDC25A	6.69e-05	3	165	2	22435685
Pubmed	Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing.	MTOR KDR	6.69e-05	3	165	2	25878330
Pubmed	Regulation of ATRIP protein abundance by RAD9 in the DNA damage repair pathway.	ATR RAD9A	6.69e-05	3	165	2	26667770
Pubmed	Asymmetric CLASP-dependent nucleation of noncentrosomal microtubules at the trans-Golgi network.	CLASP1 CLASP2	6.69e-05	3	165	2	17543864
Pubmed	Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.	ATR FANCD2	6.69e-05	3	165	2	16943440
Pubmed	Characterization of human variants in obesity-related SIM1 protein identifies a hot-spot for dimerization with the partner protein ARNT2.	SIM1 SIM2	6.69e-05	3	165	2	24814368
Pubmed	Differential roles for Chk1 and FANCD2 in ATR-mediated signalling for psoralen photoactivation-induced senescence.	ATR FANCD2	6.69e-05	3	165	2	21995812
Interaction	YWHAG interactions	SLC4A7 GBF1 CLASP1 RTCB MYCBP2 DOCK11 STXBP4 CAPNS1 CLASP2 PAK6 RB1CC1 TTK DENND2B ARAF FANCD2 PLEKHG1 VPS13D MTOR SHPRH KDR TANC1 SLFN11 USP54 CDC25A DYNC1H1 KIF1C	4.01e-06	1248	157	26	int:YWHAG
Interaction	YWHAQ interactions	CACNA1S SLC4A7 GBF1 CLASP1 RTCB MYCBP2 DOCK11 CAPNS1 CLASP2 PAK6 DENND2B ARAF FANCD2 PPP4R3B VPS13D MTOR TLN1 COPS4 TANC1 SLFN11 USP54 CDC25A DYNC1H1 KIF1C	6.00e-06	1118	157	24	int:YWHAQ
Interaction	CLEC16A interactions	MYCBP2 CAPNS1 ELP1 FAM91A1 NCAPH2 TTK ARAF GGCX FANCD2 PPP4R3B VPS13D WDR11 MTOR NCAPD2 ECEL1 USP54 UBE3C	8.65e-06	629	157	17	int:CLEC16A
Interaction	GYPA interactions	GBF1 ATR CLASP1 CCNYL1 MTOR NCAPD2 TIMELESS GPRC5D UBE3C	9.18e-06	174	157	9	int:GYPA
Interaction	TRIM52 interactions	FAM91A1 YTHDC2 NCAPH2 NCAPG2 WDR11 ASPM TANC1 USP54	9.76e-06	133	157	8	int:TRIM52
Interaction	FAM174A interactions	GBF1 ATR PEX6 FAM91A1 NCAPH2 TTK NCAPG2 FANCD2 JAK1 MTOR	1.06e-05	224	157	10	int:FAM174A
Interaction	NCAPG2 interactions	NARS1 NCAPH2 NCAPG2 FANCD2 FBXO38 NCAPD2 ASPM	1.33e-05	100	157	7	int:NCAPG2
Interaction	YWHAH interactions	SLC4A7 GBF1 CLASP1 RTCB MYCBP2 DOCK11 STXBP4 CAPNS1 CLASP2 PAK6 RB1CC1 TTK DENND2B ARAF FANCD2 PLEKHG1 VPS13D MTOR OSBPL5 TANC1 USP54 CDC25A KIF1C	1.51e-05	1102	157	23	int:YWHAH
Interaction	DSCR9 interactions	MYCBP2 NARS1 NBEA SGSM2 COPS4 LRP4 IFT122 DYNC1H1	2.02e-05	147	157	8	int:DSCR9
Interaction	GPR45 interactions	GBF1 ATR ARFGEF1 PEX6 ACAD10 NCAPG2 GGCX FANCD2 JAK1 MTOR UBE3C	2.42e-05	300	157	11	int:GPR45
Interaction	CXCR4 interactions	FAM91A1 UQCC2 NCAPH2 ACAD10 TTK GGCX JAK1 WDR11 MTOR NCAPD2	3.24e-05	255	157	10	int:CXCR4
Interaction	HCST interactions	GBF1 ATR NARS1 FAM91A1 ACAD10 GGCX JAK1 MTOR UBE3C	3.38e-05	205	157	9	int:HCST
Interaction	OPALIN interactions	SLC4A7 ATR ARFGEF1 NCAPG2 ARAF FANCD2 JAK1 MTOR UBE3C	3.93e-05	209	157	9	int:OPALIN
Interaction	MAS1 interactions	SLC4A7 ACAD10 TTK JAK1 EFHD1 NCAPD2	5.71e-05	86	157	6	int:MAS1
Interaction	GPR182 interactions	GBF1 ATR ARFGEF1 ACAD10 TTK NCAPG2 GGCX FANCD2 JAK1 MTOR NCAPD2 TIMELESS UBE3C	5.95e-05	455	157	13	int:GPR182
Interaction	GPR17 interactions	GBF1 ATR ARFGEF1 NCAPH2 TTK FANCD2 PPP4R3B MTOR NCAPD2 TIMELESS	7.77e-05	283	157	10	int:GPR17
Interaction	SPN interactions	GBF1 ATR NCAPG2 FANCD2 MTOR	8.13e-05	57	157	5	int:SPN
Interaction	LRRC25 interactions	ATR ARFGEF1 TTK NCAPG2 GGCX MTOR GPRC5D UBE3C	1.03e-04	185	157	8	int:LRRC25
Interaction	HLA-B interactions	GBF1 ATR ARFGEF1 FAM91A1 NCAPH2 GGCX FANCD2 WDR11 UBE3C	1.10e-04	239	157	9	int:HLA-B
Cytoband	Ensembl 112 genes in cytogenetic band chrXq26	CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 USP26 CT45A8 CT45A3 CT45A5	7.49e-10	171	165	10	chrXq26
Cytoband	1p36.21	PRAMEF25 PRAMEF9 PRAMEF15 CASP9 PRAMEF4 PRAMEF11	1.13e-07	63	165	6	1p36.21
Cytoband	Xq26.3	CT45A6 CT45A1 CT45A2 CT45A3 CT45A5	4.55e-06	67	165	5	Xq26.3
Cytoband	12p13.3	PRMT8 NCAPD2 GPRC5D	1.72e-04	30	165	3	12p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	PRAMEF25 PRAMEF9 PRAMEF15 CASP9 PRAMEF4 VPS13D MTOR PRAMEF27 PRAMEF11	8.52e-04	681	165	9	chr1p36
Cytoband	5q32	ARSI FBXO38 SPINK5	9.88e-04	54	165	3	5q32
GeneFamily	PRAME family	PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	5.15e-09	24	109	6	686
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RASA1 DOCK11 DGKH PLEKHG1 IPCEF1 OSBPL5 CADPS2	2.51e-04	206	109	7	682
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL	CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 STC1 CT45A9 CT45A8 PLEKHG1 CT45A3 CT45A5 LRP4	2.52e-12	104	164	12	M45682
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL	CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 STC1 CT45A9 CT45A8 CT45A3 CT45A5	1.73e-11	69	164	10	M45681
Coexpression	GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN	ZNF211 USP25 SIM1 JAK1 PPP4R3B SGSM2 IPCEF1 CADPS2 CX3CR1 RAD9A SPINK5	4.44e-08	195	164	11	M5445
Coexpression	FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	TTK NCAPG2 FANCD2 NCAPD2 ASPM CCNA1 LRP4 TIMELESS	2.74e-05	190	164	8	M761
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	ADAD1 PRAMEF15 PRAMEF4 KCNG1 PRAMEF11	2.90e-05	57	164	5	MM1262
Coexpression	GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN	USE1 SIM2 IFNA6 CARD6 GPRC5D MGAT4C CX3CR1	3.38e-05	143	164	7	M2956
Coexpression	GSE2826_XID_VS_BTK_KO_BCELL_UP	TCEA2 RTCB PEX6 TLN1 KDR ALCAM CX3CR1 RAD9A	3.95e-05	200	164	8	M4900
Coexpression	GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP	HSCB ARFGEF1 ARSI S1PR3 MAD2L1BP ABCG1 LRP4 KDR	3.95e-05	200	164	8	M4026
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 STC1 CT45A9 CT45A5 LRP4 TANC1	7.26e-09	157	164	9	b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 STC1 CT45A9 CT45A5 LRP4 TANC1	4.35e-08	193	164	9	2f203f6f0c2135acb046c9351a633c3b5b254a46
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 STC1 CT45A9 KCNG1 CT45A5	2.33e-07	170	164	8	fefb07a7e308b620f946b9ff2b01e1796446fe38
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NBEA ATP10B DGKH SGSM2 IPCEF1 RASEF TANC1 USP54	3.45e-07	179	164	8	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 SLC4A7 DGKH SIM2 ITPR3 EFHD1 ALCAM DNAH6	5.22e-07	189	164	8	e059be2965cca70ff5576df055d0af1775b76e00
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 STC1 CT45A9 CT45A5 LRP4	5.43e-07	190	164	8	d24af6af3271e34afab744352afd28be8a7cc5c3
ToppCell	COVID-19_Moderate-T/NK_proliferative\|COVID-19_Moderate / disease group, cell group and cell class	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	7.41e-07	198	164	8	166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCell	COVID-19_Moderate-T/NK_proliferative\|World / disease group, cell group and cell class	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	7.41e-07	198	164	8	bf0131fbca6032e1aab4aa807f8c1d3be689cb7f
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Mild / Disease, condition lineage and cell class	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.00e-07	200	164	8	6126a3bbafe2110fba0c1c4493035df4e8193d22
ToppCell	Control-Control-Lymphocyte-T/NK-T/NK_proliferative\|Control / Disease, condition lineage and cell class	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.00e-07	200	164	8	6cf63dd57f6bc0c42e7182322dd24ff9afbe9186
ToppCell	healthy_donor-Lymphocytic-Proliferative_Lymphocyte\|healthy_donor / Disease condition, Lineage, Cell class and subclass	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.00e-07	200	164	8	e4eb915c29909cf8535a3603c68976545c05e54b
ToppCell	mild-T/NK_proliferative\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.00e-07	200	164	8	25b4a1a33348e274bd4457efc0d6faa5421c3d31
ToppCell	healthy_donor-Lymphocytic-Proliferative_Lymphocyte-\|healthy_donor / Disease condition, Lineage, Cell class and subclass	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.00e-07	200	164	8	415e7556b5ac45688e2c6c30a52bd40e0eb27c7d
ToppCell	Biopsy_Other_PF-Immune-Proliferating_Macrophages\|Biopsy_Other_PF / Sample group, Lineage and Cell type	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.00e-07	200	164	8	61473e8613f39a92002d5b631e6bd563735566e4
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.00e-07	200	164	8	7e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCell	BL-critical-LOC-Lymphoid-Treg\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.00e-07	200	164	8	04d95a9102248e98eed069840ea6d3d23a243fd5
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.00e-07	200	164	8	9775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCell	mild-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.00e-07	200	164	8	63cc57b9331459efbb73051d174d198a3568b938
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	COL4A4 PLEKHG1 GPRC5D ECEL1 TANC1 ALCAM USP54	3.28e-06	170	164	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	Dividing_Macrophages-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A	4.45e-06	178	164	7	1893fadac2ec3d5de0a641e57b7b2f962012a9ba
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRMT8 SLC4A7 STXBP4 SIM1 SIM2 IPCEF1 CADPS2	4.78e-06	180	164	7	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DGKH TTK NCAPG2 FANCD2 NCAPD2 ASPM DSCC1	4.78e-06	180	164	7	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	COPD-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	DENND2B STC1 PLEKHG1 PXDN KDR TANC1 CADPS2	4.96e-06	181	164	7	61608123959483ff60f07d8467996853c4371b6a
ToppCell	COPD-Endothelial-VE_Capillary_A\|COPD / Disease state, Lineage and Cell class	DENND2B STC1 PLEKHG1 PXDN KDR TANC1 CADPS2	5.53e-06	184	164	7	5f4f7775d488ececf086c71441defecbee9d8a9c
ToppCell	COPD-Endothelial-VE_Peribronchial\|COPD / Disease state, Lineage and Cell class	STC1 PLEKHG1 PXDN KDR TANC1 CADPS2 NOS3	5.93e-06	186	164	7	23c7d0e8372a71546d687278b985f761d282f92f
ToppCell	10x5'-Liver-Lymphocytic_NK-Cycling_NK\|Liver / Manually curated celltypes from each tissue	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A	6.36e-06	188	164	7	5eb94e652a734c6f15c68a178e9d05f0febcf34c
ToppCell	3'_v3-blood-Lymphocytic_T_CD4/8-lo-Cycling_T\|blood / Manually curated celltypes from each tissue	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	6.36e-06	188	164	7	714ccbcf826f26d39757931a3b8abbd952f4cddc
ToppCell	PBMC-Mild-cDC_12\|Mild / Compartment, Disease Groups and Clusters	TTK NCAPG2 ASPM TIMELESS TANC1 CDC25A DSCC1	6.59e-06	189	164	7	946c95d2ecc36b241f58e8c4ad6455fe47c762fa
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TTK NCAPG2 FANCD2 NCAPD2 ASPM CDC25A DSCC1	6.59e-06	189	164	7	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 STC1 CT45A9 CT45A5	6.82e-06	190	164	7	71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T\|GI_small-bowel / Manually curated celltypes from each tissue	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	7.06e-06	191	164	7	e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCell	Mild-T/NK_proliferative\|World / Disease group and Cell class	NCAPH2 NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS DSCC1	7.06e-06	191	164	7	9dba5526fd5ea8065ad305feb2ee562335f887c6
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	7.55e-06	193	164	7	cf680afddc08b6481f1b3eee9c57acfaebeac6f0
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	7.81e-06	194	164	7	f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell	3'_v3-blood-Lymphocytic_NK-Cycling_NK\|blood / Manually curated celltypes from each tissue	NCAPH2 TTK NCAPG2 ASPM TIMELESS CDC25A DSCC1	7.81e-06	194	164	7	bf9734abaad603ade2a6a6940918aaf1e1c4e2cd
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL4A4 MYO5B PIP5K1B RASEF ALCAM USP54 CADPS2	7.81e-06	194	164	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Control-Lymphoid_T/NK-T/NK_proliferative\|Control / Disease group, lineage and cell class	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	7.81e-06	194	164	7	9bbb124001fba7450f4639f47f9b720a483e7242
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CT45A10 TTK NCAPG2 STC1 FANCD2 ASPM TIMELESS	7.81e-06	194	164	7	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	7.81e-06	194	164	7	a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	7.81e-06	194	164	7	17744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	7.81e-06	194	164	7	e14f66f7584909621b776292fbd52808273fd2ee
ToppCell	Control-T/NK_proliferative\|Control / Disease condition and Cell class	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.35e-06	196	164	7	7b7bc25aef49bfd64f79303a92d527bf8188f7a6
ToppCell	COVID-19_Severe-T/NK_proliferative\|COVID-19_Severe / Disease condition and Cell class	TTK NCAPG2 FANCD2 ASPM TIMELESS CDC25A DSCC1	8.63e-06	197	164	7	718a84e9a8248080f2d964e7c6a3ba183ece9592
ToppCell	distal-3-Hematologic-Proliferating_NK/T\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS DSCC1	8.92e-06	198	164	7	aa23119d73554733981df474648e59918d04edfc
ToppCell	severe-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.92e-06	198	164	7	4d8591eabb543ed789f963b507a07c560c76a7c9
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	STXBP4 NBEA S1PR3 CCNYL1 EFHD1 SPOCD1 KIF1C	8.92e-06	198	164	7	cc2b5b632e73e44bb60050f0db10d8f0dbb859fa
ToppCell	COVID-19_Severe-T/NK_proliferative\|World / disease group, cell group and cell class	TTK NCAPG2 FANCD2 ASPM TIMELESS CDC25A DSCC1	8.92e-06	198	164	7	48045689d0969ff0a14eee7086b8e19b0d6b6065
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	8.92e-06	198	164	7	6981cd5b1585c8ae6febdf0c4fb83067127f106c
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	TTK NCAPG2 FANCD2 NCAPD2 ASPM CCNA1 TIMELESS	8.92e-06	198	164	7	dada1c19a261c8e1090957cd7e37f2a43a9fe14f
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TTK NCAPG2 FANCD2 ASPM TIMELESS CDC25A DSCC1	9.22e-06	199	164	7	11c3d9fe811a4619347f47d2b0e94066e3085625
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS DSCC1	9.22e-06	199	164	7	e98ff036d04fc78dffef156bdc0d644532274067
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTK NCAPG2 FANCD2 ASPM TIMELESS CDC25A DSCC1	9.22e-06	199	164	7	36c80907b2ec1cbcd1b4e841e6c02a4792591d74
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS DSCC1	9.22e-06	199	164	7	305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	TTK NCAPG2 FANCD2 ASPM TIMELESS CDC25A DSCC1	9.22e-06	199	164	7	bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c
ToppCell	COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Mild / Disease group, lineage and cell class	TTK NCAPG2 FANCD2 ASPM TIMELESS CDC25A DSCC1	9.22e-06	199	164	7	ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c
ToppCell	Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	TTK NCAPG2 FANCD2 ASPM TIMELESS CDC25A DSCC1	9.22e-06	199	164	7	4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS DSCC1	9.22e-06	199	164	7	7feedb0bf84a3361c8ab5b6674ff64e8ff140c23
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTK NCAPG2 FANCD2 ASPM TIMELESS CDC25A DSCC1	9.22e-06	199	164	7	7beb0e07a27fea94674f24eb61c381b0de38ed3e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS DSCC1	9.22e-06	199	164	7	123fbf2122aa221d8cbf3aef9361ba0982c07695
ToppCell	COVID-19_Mild-T/NK_proliferative\|COVID-19_Mild / Disease condition and Cell class	TTK NCAPG2 FANCD2 ASPM TIMELESS CDC25A DSCC1	9.22e-06	199	164	7	9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LINC01559 CYP2C18 MYO5B NBEA ATP10B RASEF ALCAM	9.22e-06	199	164	7	7223f853335492ca617dbec3e4b6872a8a463a45
ToppCell	COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Severe / Disease group, lineage and cell class	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS DSCC1	9.22e-06	199	164	7	ddae7fe7633661f15d3c79f5187415ffbfecce67
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS DSCC1	9.22e-06	199	164	7	fba48342066aab41a8bcb20db40a6df0158e1cbe
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LINC01559 CYP2C18 MYO5B NBEA ATP10B RASEF ALCAM	9.22e-06	199	164	7	e03bdc7cb825e287f41b834ec6061d23c1c03b04
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS DSCC1	9.22e-06	199	164	7	6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6
ToppCell	distal-Hematologic-Proliferating_Macrophage\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A	9.53e-06	200	164	7	3835a8a9739b8cd5bf19c40765ef76907ac1ad38
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Severe / Disease, condition lineage and cell class	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS DSCC1	9.53e-06	200	164	7	0892603e604c2a945dd720685d45970f855bd5d3
ToppCell	3'_v3-Lung-Lymphocytic_NK-Cycling_NK\|Lung / Manually curated celltypes from each tissue	TTK NCAPG2 NCAPD2 ASPM TIMELESS CDC25A DSCC1	9.53e-06	200	164	7	381bafdde6492f020ae93ab8fffa6215c631c570
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A	9.53e-06	200	164	7	04bf9e6a0fbd792b49eed63dabba5d6fafed8c07
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TTK NCAPG2 FANCD2 ASPM TIMELESS CDC25A DSCC1	9.53e-06	200	164	7	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TTK NCAPG2 FANCD2 NCAPD2 ASPM TIMELESS CDC25A	9.53e-06	200	164	7	f6b5320cdfe640a71e6e2df26f30d42e64b1c921
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5B NBEA PIP5K1B RASEF TANC1 ALCAM CADPS2	9.53e-06	200	164	7	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYTL1 STC1 PLEKHG1 PXDN IPCEF1 KDR NOS3	9.53e-06	200	164	7	310c75e13be9194312a8b686804edcf13d44caf5
ToppCell	Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Thalamus / BrainAtlas - Mouse McCarroll V32	SIM1 PAK6 STC1 GPR83 ECEL1 FRMPD3	1.84e-05	148	164	6	afebb64365c94b9476494bffe7c364677f19c8cf
ToppCell	Thalamus-Neuronal-Inhibitory\|Thalamus / BrainAtlas - Mouse McCarroll V32	SIM1 PAK6 STC1 GPR83 ECEL1 FRMPD3	1.84e-05	148	164	6	5f82e5ecacfd223020b8ee975c17d68c1fe6db38
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC25A18 PAK6 ITPR3 EFHD1 FRMPD3 MGAT4C	2.48e-05	156	164	6	60f1ce38e34b582f589db1e0d6139282c1902b2b
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 STC1 CT45A9	2.85e-05	160	164	6	5cd4fbbd2ce671a8377416eff94041a111375dee
ToppCell	PND01-03-samps\|World / Age Group, Lineage, Cell class and subclass	ACER2 COL4A4 EFCAB6 DGKH TEX11 SPINK5	2.96e-05	161	164	6	1973b112d8d67aacc02751797d0148e7b53bfa66
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACER2 SLC25A18 GARNL3 S1PR3 FANCD2 PIP5K1B	3.63e-05	167	164	6	b4ef07117d14da3d5fbced949e4dfcb01c392295
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACER2 SLC25A18 GARNL3 S1PR3 FANCD2 PIP5K1B	3.63e-05	167	164	6	94fc7df7ca55cd722a8dbd153201a29891217473
ToppCell	facs-Skin-Anagen-24m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTK CHRM5 KCNG1 LRP4 HFM1 ONECUT3	3.63e-05	167	164	6	02c89069dcd0e87f7502e32b14e7cbd3cab81a09
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACER2 SLC25A18 GARNL3 S1PR3 FANCD2 PIP5K1B	3.63e-05	167	164	6	eff3723fe60755272eca237459165e436e919ece
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNHD1 TCEA2 ABCG1 KDR TANC1 DSCC1	3.88e-05	169	164	6	8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)--\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DNHD1 COL4A4 CHRM5 HFM1 FRMPD3	4.36e-05	105	164	5	c7528276fee8f6d2cb4639069bc87413b0288025
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DNHD1 COL4A4 CHRM5 HFM1 FRMPD3	4.36e-05	105	164	5	7bcf3345a21a1ade717128be127e9fe12ae40011
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DNHD1 COL4A4 CHRM5 HFM1 FRMPD3	4.36e-05	105	164	5	62e89b92bb8c5187ab0205aebd018b4178710bb0
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACER2 FAM91A1 ITPR3 CCNYL1 RASEF TSTD2	4.42e-05	173	164	6	4968712af1cca8c932abd3323631d7dcaffd4a66
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ACER2 COL4A4 MYO5B CAPNS2 ITPR3 USP54	4.56e-05	174	164	6	edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)\|367C / Donor, Lineage, Cell class and subclass (all cells)	ACER2 COL4A4 MYO5B CAPNS2 ITPR3 USP54	4.56e-05	174	164	6	65539f69100db0b7d90b1b39ee15ab8281f86461
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPH2 TTK NCAPG2 NCAPD2 ASPM NOS3	4.71e-05	175	164	6	d43ae33a6256606ce848247cad32d74f21b38988
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK11 ARFGEF1 DGKH IPCEF1 ALCAM CX3CR1	4.71e-05	175	164	6	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T\|Lung / Manually curated celltypes from each tissue	TTK NCAPG2 NCAPD2 ASPM TIMELESS DSCC1	4.86e-05	176	164	6	a40dfd8c4ba16757ff929b2f03a0628acf334de4
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5B NCAPD2 ASPM PIP5K1B ALCAM SPINK5	5.02e-05	177	164	6	a68c3688f12aee22f3cb4049c4bccacbacb0fae6
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	GBF1 FBXO38 CCNYL1 WDR11 UBE3C SPOCD1	5.18e-05	178	164	6	536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAG1 TTK NCAPG2 NCAPD2 ASPM DSCC1	5.34e-05	179	164	6	ac987c9425a1b4106d1b8779a2c5461383eae2ae
ToppCell	control-Lymphoid-NKT-proliferating\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TTK NCAPG2 FANCD2 NCAPD2 ASPM CDC25A	5.51e-05	180	164	6	535535a67b3f3320bad2f98b1bc98a7b0ee77840
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PAK6 TTK NCAPG2 FANCD2 NCAPD2 ASPM	5.51e-05	180	164	6	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPG2 FANCD2 ABCG1 EFHD1 NCAPD2 ASPM	5.51e-05	180	164	6	43fd5c498a87bb078d101298b472656f3294686a
ToppCell	droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ACER2 CYTL1 CCNYL1 IFT122 CADPS2 NOS3	5.68e-05	181	164	6	2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPR EGLN1 CASP9 PLEKHG1 CADPS2 CHST7	5.68e-05	181	164	6	fcc94f04dae98b817ec06b282d2e887804d37ae5
Disease	high grade glioma (is_marker_for)	ARAF MTOR ASPM KDR NOS3	2.03e-06	42	146	5	DOID:3070 (is_marker_for)
Disease	Intestinal Perforation	IFNA2 NOS3	7.27e-05	3	146	2	C0021845
Disease	Malignant neoplasm of breast	STXBP4 ELP1 MANEA SIM1 RB1CC1 PKDREJ IFNA2 ARAF EPG5 RPRD1A MTOR KDR TIMELESS USP54 SPOCD1 NOS3	8.79e-05	1074	146	16	C0006142
Disease	odorant-binding protein 2b measurement	OBP2B OBP2A	2.41e-04	5	146	2	EFO_0801859
Disease	prostate cancer (is_implicated_in)	JAK1 MTOR CCNA1 CDC25A NOS3	2.97e-04	117	146	5	DOID:10283 (is_implicated_in)
Disease	hypertension (implicated_via_orthology)	RAG1 TRHR EGLN1 MTOR NOS3	4.50e-04	128	146	5	DOID:10763 (implicated_via_orthology)
Disease	Adenocarcinoma of lung (disorder)	SLC4A7 ATR RASA1 ARHGAP35 ARAF KDR	5.80e-04	206	146	6	C0152013
Disease	Polycythemia Vera	IFNA2 JAK1	6.68e-04	8	146	2	C0032463
Disease	Retinal Pigment Epithelial Detachment	CASP9 IFNA2	8.56e-04	9	146	2	C0339546
Disease	Nodular glomerulosclerosis	DGKH KDR NOS3	1.10e-03	41	146	3	C0017667
Disease	transient cerebral ischemia (biomarker_via_orthology)	CASP9 JAK1 MTOR NOS3 CX3CR1	1.13e-03	157	146	5	DOID:224 (biomarker_via_orthology)
Disease	virologic response measurement, response to abacavir	MANEA PLEKHG1 SPOCD1	1.18e-03	42	146	3	EFO_0006905, EFO_0006906
Disease	Retinal Detachment	CASP9 IFNA2	1.30e-03	11	146	2	C0035305
Disease	Tachycardia, Ventricular	RYR2 NOS3	1.30e-03	11	146	2	C0042514
Disease	Diarrhea	MYO5B IFNA2	1.30e-03	11	146	2	C0011991
Disease	Diabetic Nephropathy	DGKH KDR NOS3	1.35e-03	44	146	3	C0011881
Disease	complement component C7 measurement	MROH2B CARD6	1.55e-03	12	146	2	EFO_0008093
Disease	pulmonary embolism (biomarker_via_orthology)	NOS3 CX3CR1	1.55e-03	12	146	2	DOID:9477 (biomarker_via_orthology)
Disease	Malformations of Cortical Development	MTOR DYNC1H1	2.13e-03	14	146	2	C1955869
Disease	Cortical Dysplasia	MTOR DYNC1H1	2.13e-03	14	146	2	C0431380
Disease	Beta blocking agent use measurement	SLC4A7 PLEKHG1 CDC25A NOS3	2.52e-03	114	146	4	EFO_0009929
Disease	creatinine measurement, glomerular filtration rate	CACNA1S CASP9 STC1 PIP5K1B	2.77e-03	117	146	4	EFO_0004518, EFO_0005208
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	MTOR CDC25A	2.79e-03	16	146	2	DOID:0110861 (implicated_via_orthology)
Disease	primary autosomal recessive microcephaly (is_implicated_in)	NCAPD2 ASPM	2.79e-03	16	146	2	DOID:0070296 (is_implicated_in)
Disease	obsolete_red blood cell distribution width	ACER2 HSCB ADAD1 ZNF211 CYP2C18 ATR CLASP1 NCAPH2 DENND2B EPG5 PLEKHG1 COPS4 HFM1 LRRC14 RAD9A	2.84e-03	1347	146	15	EFO_0005192
Disease	MAJOR AFFECTIVE DISORDER 2	KCNQ2 GPRC5D	3.15e-03	17	146	2	C1839839
Disease	Inborn Errors of Metabolism	MYO5B ABCD4	3.15e-03	17	146	2	C0025521
Disease	Kuhnt-Junius degeneration (is_implicated_in)	KDR NOS3	3.15e-03	17	146	2	DOID:10873 (is_implicated_in)
Disease	Uremia	KDR NOS3	3.15e-03	17	146	2	C0041948
Disease	Bone marrow hypocellularity	MYSM1 FANCD2	3.53e-03	18	146	2	C1855710
Disease	Prostatic Neoplasms	RAG1 CYP2C18 ATR CAPNS1 CASP9 PAK6 JAK1 NOS3 SPINK5	3.67e-03	616	146	9	C0033578
Disease	Malignant neoplasm of prostate	RAG1 CYP2C18 ATR CAPNS1 CASP9 PAK6 JAK1 NOS3 SPINK5	3.67e-03	616	146	9	C0376358
Disease	Malignant Neoplasms	ATR MTOR KDR NOS3	3.82e-03	128	146	4	C0006826
Disease	systolic blood pressure, alcohol drinking	SLC4A7 ACAD10 PLEKHG1 NOS3	3.82e-03	128	146	4	EFO_0004329, EFO_0006335
Disease	portal hypertension (implicated_via_orthology)	MTOR NOS3	3.93e-03	19	146	2	DOID:10762 (implicated_via_orthology)
Disease	polycystic kidney disease (biomarker_via_orthology)	MTOR NOS3	3.93e-03	19	146	2	DOID:0080322 (biomarker_via_orthology)
Disease	myocardial infarction (implicated_via_orthology)	MTOR KDR NOS3	4.32e-03	66	146	3	DOID:5844 (implicated_via_orthology)
Disease	urinary microalbumin measurement	COL4A4 YTHDC2	4.36e-03	20	146	2	EFO_0010967
Disease	sleep measurement	RYR2 PXDN RASEF KIF1C	4.61e-03	135	146	4	EFO_0004870
Disease	Mammary Carcinoma, Human	STXBP4 ELP1 SIM1 RB1CC1 ARAF MTOR KDR NOS3	4.73e-03	525	146	8	C4704874
Disease	Mammary Neoplasms, Human	STXBP4 ELP1 SIM1 RB1CC1 ARAF MTOR KDR NOS3	4.73e-03	525	146	8	C1257931
Disease	esophagus adenocarcinoma (is_implicated_in)	KDR NOS3	4.80e-03	21	146	2	DOID:4914 (is_implicated_in)
Disease	status epilepticus (implicated_via_orthology)	MTOR CX3CR1	4.80e-03	21	146	2	DOID:1824 (implicated_via_orthology)
Disease	Mammary Neoplasms	STXBP4 ELP1 SIM1 RB1CC1 ARAF MTOR KDR NOS3	4.84e-03	527	146	8	C1458155

Protein segments in the cluster

Peptide	Gene	Start	Entry
NALTMCLARLLFFKD	USP26	336	Q9BXU7
QLKECISVLFMFTRR	EPG5	431	Q9HCE0
CILFKRTFLSIMRDS	ABCG1	406	P45844
LLIAELKRCDNMRVF	ACER2	161	Q5QJU3
CKLRSFFRKLNTRLM	ARSI	551	Q5FYB1
KDAFLVFRSLCKLSM	ARFGEF1	421	Q9Y6D6
IVLMRCSFRLTKSLA	COL4A4	6	P53420
FFESIIKEAARCMRR	CT45A5	161	P0DMU8
FLREFGRLCSEMLKT	ACAD10	101	Q6JQN1
ASRLCKAAMLSRFNL	ADAD1	506	Q96M93
FFPSCDMRKDLRLAL	CX3CR1	261	P49238
SSRCLLLRRKMAENA	PRMT8	6	Q9NR22
MATRLSKFFSLEREL	DNHD1	1851	Q96M86
ERFCRQLSSMASKLI	ABCD4	151	O14678
DFKGLRRMSRTFSEC	DENND2B	221	P78524
DKDLCRAAMRRSFSA	CCNYL1	331	Q8N7R7
FFESIIKEAARCMRR	CT45A7	161	P0DMV0
RRAACRLFTSEKMVK	ASPM	766	Q8IZT6
RLDRFCSALSSMLER	ATXN7L2	431	Q5T6C5
RSKIERRMNIDIFFC	ATP10B	306	O94823
KSVCMTLFLLALRAR	RAG1	431	P15918
KDPDILFMRCQLSRL	RASA1	666	P20936
SFLMRLCKNEFRENI	RASEF	556	Q8IZ41
LRCKILMKSFLSVFR	RAD9A	71	Q99638
LRTDNISFMLKRCCQ	JAK1	531	P23458
FENFTLDMARVCSKR	ITPR3	1441	Q14573
MIQKECAAIRSSFRE	AP1G1	26	O43747
VESLVRKCFDSMSRL	RB1CC1	321	Q8TDY2
FEILDKMRCLRKRST	MGAT4C	11	Q9UBM8
LKRRLFRSMFLSTAA	PAK6	256	Q9NQU5
AVRCLDMSASRKKLA	IFT122	516	Q9HBG6
CLRRLFRAIFMADAF	MAD2L1BP	186	Q15013
FFESIIKEAARCMRR	CT45A10	161	P0DMU9
MCRAVFLTEALERAK	SPINK5	951	Q9NQ38
DLMNQCRSSKKFFRR	FAM91A1	136	Q658Y4
RAVCVMRFLVSKRKF	KCNQ2	541	O43526
CSIARLNKRSFFMIS	PDPR	576	Q8NCN5
SLCSDAMTAALKRRV	PEX6	916	Q13608
TLQRDCRVLESFKIM	PIP5K1B	251	O14986
FFESIIKEAARCMRR	CT45A3	161	Q8NHU0
QRSRMLATLFKDERC	COPS4	241	Q9BT78
LFMEAFSRRRCEALK	PRAMEF15	41	P0DUQ1
FSRRRCEALKLMVQA	PRAMEF15	46	P0DUQ1
IEALAALKMRELCRT	KIF1C	771	O43896
MRNLKLFRTLEFRDI	ELP1	1	O95163
LRLLREMCALSFQEE	KCNG1	136	Q9UIX4
SKHTFLALCALRFMR	PPP4R3B	581	Q5MIZ7
TIMNSFCRRDLVFLL	CYTL1	101	Q9NRR1
TPFRRLMLCAENRKE	DGKH	131	Q86XP1
FTFMREDRCIQKKIL	OBP2A	66	Q9NY56
NFRIELKALLSMCQR	GPR83	351	Q9NYM4
AQRKVRAFFRSCLDM	ECEL1	176	O95672
MAKFRRRTCIILALF	MANEA	1	Q5SRI9
LLRSQSCRLCSFRKM	MTERF2	6	Q49AM1
LFRKAFDPRVLCMDE	NOS3	541	P29474
RLSTRDKYIQMLACR	HFM1	671	A2PYH4
FKDFLCISLRTFVMR	FBXO38	226	Q6PIJ6
RRESLCRFKDSMLAS	KCTD18	26	Q6PI47
FTFMREDRCIQKKIL	OBP2B	66	Q9NPH6
AMRRLLSDCLKFQRE	ARAF	541	P10398
DLRKDCRLMEFNSLI	ATR	2331	Q13535
CRLMEFNSLINKCLR	ATR	2336	Q13535
FFESIIKEAARCMRR	CT45A1	161	Q5HYN5
FFESIIKEAARCMRR	CT45A9	161	P0DMV2
EAMFTSLRRLCKAAI	DNAH6	1286	Q9C0G6
FLTMSRRRISCKDLG	IPCEF1	26	Q8WWN9
LCLNMDRSRKVLPDF	CARD6	291	Q9BX69
FELDADKICRAAARM	DSCC1	261	Q9BVC3
SLASFLKRCLTLMDR	DOCK11	1026	Q5JSL3
LKRCLTLMDRGFIFN	DOCK11	1031	Q5JSL3
LLAFLFLMRKIQDCS	GPRC5D	41	Q9NZD1
ELRRVLETFCMKLRD	EFCAB6	196	Q5THR3
SSAFFRLFRVMRLIK	CACNA1S	1231	Q13698
IKLAANDFFRRLLME	SLC25A18	81	Q9H1K4
YCRLLLDSRKMVFSR	FRMPD3	486	Q5JV73
DCEKLRRRFSSLHFM	CASP9	186	P55211
FFESIIKEAARCMRR	CT45A2	161	Q5DJT8
FLDRFLSCMSVLRGK	CCNA1	271	P78396
SCLVRLDAMFRAFKS	CAPNS2	211	Q96L46
SCLVRLDAMFRAFKS	CAPNS1	231	P04632
SDMLEACVKRTRTAF	CADPS2	1046	Q86UW7
KMENLLRCSRCRSSF	EGLN1	26	Q9GZT9
LAQMRRISLFSCLKD	IFNA2	41	P01563
FFESIIKEAARCMRR	CT45A8	161	P0DMV1
MASEELACKLERRLR	EFHD1	1	Q9BUP0
DLCTENAIMLKRFNR	DYNC1H1	3571	Q14204
RICFEMRLSELLRKS	GBF1	166	Q92538
FMQRALQDLRKTACS	C4orf48	56	Q5BLP8
KEIRRFCLMTLRNFG	CYP2C18	121	P33260
CFISKRFRTMAAATL	GPR139	286	Q6DWJ6
ASKEMRRAFFRLVCN	S1PR3	301	Q99500
LSKQRKRAVVACFRM	RYR2	3591	Q92736
SNARISDEKRFVCML	ALCAM	101	Q13740
FFESIIKEAARCMRR	CT45A6	161	P0DMU7
CRRFVARSLCIILMK	GARNL3	6	Q5VVW2
CRLNTMDLLLDLFFK	PPP6R2	366	O75170
AKERSFMCSLIFLTL	FANCD2	776	Q9BXW9
VMRTTNLDNRCKLFD	CDC25A	246	P30304
PEFQRMSALRLAACK	ONECUT3	386	O60422
MKEEAFLRRRFSLCP	OSBPL5	1	Q9H0X9
LAQMRRISLFSCLKD	IFNA6	41	P05013
MTRTFLIFRLSLCSK	OR1P1	171	Q8NH06
KEIRMEAARTCSRLL	MTOR	616	P42345
LMDCNRSFRVDTAKL	HSCB	76	Q8IWL3
ALEKLMFEELRNACR	RTCB	41	Q9Y3I0
VFVRKLMDLCFTKRE	SLC4A7	1116	Q9Y6M7
NLMSQKFRAAFRKLC	TRHR	321	P34981
LKARSMVTRCFRDHF	NARS1	246	O43776
MRKRICILVFLRFAN	SLC22A10	346	Q63ZE4
LCRKLRTMFSFLTSQ	PKDREJ	2196	Q9NTG1
DMIKLFSNSRENRRC	NBEA	871	Q8NFP9
LFMEAFSRRRCEALK	PRAMEF25	41	A6NGN4
FSRRRCEALKLMVQA	PRAMEF25	46	A6NGN4
LLCESMKRQIVSRAF	SGSM2	486	O43147
LTLMALRLACDFLAR	FTSJ3	136	Q8IY81
IERSFFLRMKCVLAK	SIM2	156	Q14190
IERSFFLRMKCVLAK	SIM1	156	P81133
KLSMSEKFRDCRGLQ	SHPRH	1176	Q149N8
RSMDSREAFCFLKTK	SLFN11	141	Q7Z7L1
FQQRMDALSCFLIKR	TANC1	791	Q9C0D5
KQALRKSACRVFAME	MYCBP2	3561	O75592
LFMEAFSRRCCEALK	PRAMEF27	41	A3QJZ7
FSRRCCEALKLMVQA	PRAMEF27	46	A3QJZ7
FRAMREVATLCKLDI	WHAMM	246	Q8TF30
RLDANRLSDKIFMLF	MROH2B	176	Q7Z745
CQLRKSEMARKTFEA	STXBP4	411	Q6ZWJ1
AKRKASLAMLRAFLC	ARHGAP35	861	Q9NRY4
KVFLAIRRCSTFQRM	STC1	106	P52823
ALCNRTFRKTFKMLL	CHRM5	496	P08912
GALRDMLRSLFRCDF	CHST7	151	Q9NS84
MLRSLFRCDFSVLRL	CHST7	156	Q9NS84
FCDSQLRLLFTMLEK	NCAPD2	1051	Q15021
KVFQKMLECIARSFR	NCAPG2	956	Q86XI2
EVLASRKDFRMNTCV	NCAPH2	171	Q6IBW4
MERFLNSKARRLGSC	LINC01559	1	Q495D7
RVELKRLCEIFTRMF	CLASP1	891	Q7Z460
ELKRLCEIFTRMFAD	CLASP2	691	O75122
LFMEAFSRRRCEALK	PRAMEF4	41	O60810
FSRRRCEALKLMVQS	PRAMEF4	46	O60810
VRLLSRCEAMAAEKR	USE1	11	Q9NZ43
THLFLKMLERFCRSR	TIMELESS	506	Q9UNS1
LRKLYVFRRSFLMTC	GGCX	686	P38435
PLDACRFELMRFKTL	STON1	506	Q9Y6Q2
DRKQLTRMLADFLRC	RPRD1A	236	Q96P16
TRMLADFLRCQKEAL	RPRD1A	241	Q96P16
EAFLKMLRFVKCFLR	TAS2R9	291	Q9NYW1
NLSRRAIADMLRACK	TLN1	2206	Q9Y490
LDMFSIKRFRARAQL	SPOCD1	871	Q6ZMY3
LFMEAFSRRRCEALK	PRAMEF9	41	P0DUQ2
FSRRRCEALKLMVQA	PRAMEF9	46	P0DUQ2
TLMCLLSTQFKRLRD	PXDN	1231	Q92626
LCERFARIMLSLSRT	USP25	1036	Q9UHP3
MAASRYRRFLKLCEE	UQCC2	1	Q9BRT2
TCREIRKDFLANMRF	ZNF211	186	Q13398
LFMEAFSRRRCEALK	PRAMEF11	41	O60813
FSRRRCEALKLMVQA	PRAMEF11	46	O60813
KEMDRLLTCLNRAFV	TEX11	601	Q8IYF3
CILRFSDLDLKDMSL	TSTD2	16	Q5T7W7
MAATFAKLCRAKRLV	ELAC1	296	Q9H777
SEICRKDLLARNMSR	TTLL6	121	Q8N841
DSARRSLCKYRMLDQ	ZNF333	21	Q96JL9
ASQKRAAMLCRKRFT	YTHDC2	876	Q9H6S0
FMKRQTSRSECRDLV	TTK	296	P33981
NMREKFFRSLARLLE	ZBED9	221	Q6R2W3
DAVRNKCREMLTAAL	TCEA2	136	Q15560
LSFDKDAMVARARRL	TALDO1	111	P37837
MEFLASRKCIHRDLA	KDR	1016	P35968
TECMRNKILAKFFRE	PLEKHG1	216	Q9ULL1
DVRTCTLLREMSKNF	WDR11	596	Q9BZH6
ERLTCLFQIKRLMSL	UBE3C	136	Q15386
IFRRSFRQLTTHKCM	USP54	56	Q70EL1
NMRDTLGKCFFLRVE	VPS13D	3481	Q5THJ4
NEFKSCRSALMEQRL	JTB	91	O76095
FLAQMGRFTCLRELS	LRRC14	276	Q15048
CAQSLDKFLLFARRM	LRP4	736	O75096
QCAFRMLKARRELKA	MYO5B	891	Q9ULV0
MDKIFRRDSDLTCLQ	MYSM1	761	Q5VVJ2